NI-0801 in Allergic Contact Dermatitis

NCT01244607 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Contact Dermatitis

Interventions

DRUG: Placebo
DRUG: NI-0801

Sponsor

Light Chain Bioscience - Novimmune SA